StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Tandem Diabetes Care's total debt was $602.58M at Jun 30, 2026. For fiscal 2025 it was $310.04M, down 11.1% from the year before. The highest annual figure on record is $348.94M in fiscal 2024.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$310.04M-11.1%
FY2024Dec 31, 2024$348.94M+22.4%
FY2023Dec 31, 2023$285.04M+272.4%
FY2017Dec 31, 2017$76.54M-3.1%
FY2016Dec 31, 2016$78.96M+169.7%
FY2015Dec 31, 2015$29.28M-0.6%
FY2014Dec 31, 2014$29.44M+0.1%
FY2013Dec 31, 2013$29.40M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$602.58M+94.9%
Q1 FY2026Mar 31, 2026$601.77M+94.9%
Q4 FY2025Dec 31, 2025$310.04M-11.1%
Q3 FY2025Sep 30, 2025$309.59M-11.1%
Q2 FY2025Jun 30, 2025$309.15M-11.1%
Q1 FY2025Mar 31, 2025$308.71M+8.3%
Q4 FY2024Dec 31, 2024$348.94M+352.6%
Q3 FY2024Sep 30, 2024$348.43M+356.0%
Q2 FY2024Jun 30, 2024$347.93M+354.6%
Q4 FY2023Dec 31, 2023$285.04M+277.1%
Q2 FY2018Jun 30, 2018$77.10M+3.2%
Q1 FY2018Mar 31, 2018$76.41M+3.6%
Q4 FY2017Dec 31, 2017$76.54M-3.1%
Q3 FY2017Sep 30, 2017$75.60M+69.2%
Q2 FY2017Jun 30, 2017$74.68M–
Q1 FY2017Mar 31, 2017$73.76M–
Q4 FY2016Dec 31, 2016$78.96M–
Q3 FY2016Sep 30, 2016$44.68M–

More Tandem Diabetes Care figures

See a number that looks wrong?